Innospec (IOSP) Financials

$85.33 -0.77 (-0.89%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$85.12 -0.22 (-0.25%)

As of 05/30/2025 04:21 PM Eastern

Annual Income Statements for Innospec

This table shows Innospec's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	36	139	133	93	29	112	85	62	81	120
Consolidated Net Income / (Loss)	36	139	133	93	29	112	85	62	81	120
Net Income / (Loss) Continuing Operations	36	139	133	93	29	112	85	62	81	120
Total Pre-Tax Income	41	174	185	134	40	150	132	128	103	152
Total Operating Income	178	162	187	132	34	150	134	125	98	156
Total Gross Profit	543	591	587	435	343	466	435	403	332	346
Total Revenue	1,845	1,949	1,964	1,483	1,193	1,513	1,477	1,307	883	1,012
Operating Revenue	1,845	1,949	1,964	1,483	1,193	1,513	1,477	1,307	883	1,012
Total Cost of Revenue	1,303	1,358	1,377	1,049	850	1,047	1,042	904	551	666
Operating Cost of Revenue	1,303	1,358	1,377	1,049	850	1,047	1,042	904	551	666
Total Operating Expenses	365	430	399	303	309	316	302	278	234	190
Selling, General & Admin Expense	314	388	361	267	237	281	261	244	217	207
Research & Development Expense	48	42	39	37	31	35	33	31	25	25
Impairment Charge	0.00	0.00	0.00	0.00	20	0.00	0.00	-	-	-
Other Special Charges / (Income)	3.20	0.00	0.00	-1.80	0.00	-	-	-	-9.40	-41
Total Other Income / (Expense), net	-137	13	-2.70	2.30	6.00	0.50	-1.90	3.10	4.90	-4.00
Interest & Investment Income	9.30	2.30	-1.10	-1.50	-1.80	-4.80	-6.90	-8.20	-3.20	-4.00
Other Income / (Expense), net	-146	11	-1.60	3.80	7.80	5.30	5.00	11	8.10	0.00
Income Tax Expense	5.60	35	52	41	11	38	47	66	22	33
Basic Earnings per Share	$1.43	$5.60	$5.37	$3.78	$1.17	$4.58	$3.48	$2.56	$3.39	$4.96
Weighted Average Basic Shares Outstanding	24.93M	24.85M	24.79M	24.65M	24.56M	24.48M	24.40M	24.15M	24.00M	24.11M
Diluted Earnings per Share	$1.42	$5.56	$5.32	$3.75	$1.16	$4.54	$3.45	$2.52	$3.33	$4.86
Weighted Average Diluted Shares Outstanding	25.12M	25.02M	24.98M	24.85M	24.78M	24.73M	24.60M	24.49M	24.44M	24.61M
Weighted Average Basic & Diluted Shares Outstanding	24.96M	24.87M	24.77M	24.77M	24.60M	24.51M	24.40M	24.10M	24M	24.10M
Cash Dividends to Common per Share	$1.55	$1.41	$1.28	$1.16	$1.04	$1.02	$0.89	$0.77	$0.67	$0.61

This table shows Innospec's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	33	-70	33	31	41	38	39	29	33	26	39
Consolidated Net Income / (Loss)	33	-70	33	31	41	38	39	29	33	26	39
Net Income / (Loss) Continuing Operations	33	-70	33	31	41	38	39	29	33	26	39
Total Pre-Tax Income	44	-103	45	44	55	45	48	37	45	45	49
Total Operating Income	43	41	46	41	51	45	42	34	41	47	50
Total Gross Profit	125	136	124	127	156	156	137	150	148	152	156
Total Revenue	441	467	443	435	500	495	464	480	510	511	513
Operating Revenue	441	467	443	435	500	495	464	480	510	511	513
Total Cost of Revenue	316	331	319	308	345	339	327	330	362	359	357
Operating Cost of Revenue	316	331	319	308	345	339	327	330	362	359	357
Total Operating Expenses	83	95	79	86	105	111	95	116	107	105	106
Selling, General & Admin Expense	69	81	67	73	93	102	84	106	96	97	96
Research & Development Expense	13	13	11	12	12	8.90	12	11	11	8.40	10
Other Special Charges / (Income)	0.60	1.30	0.60	0.60	0.70	-	0.00	0.00	0.00	-	-
Total Other Income / (Expense), net	1.90	-144	-0.80	3.00	4.80	0.80	5.60	2.40	4.00	-1.40	-1.20
Interest & Investment Income	2.40	2.40	2.70	2.10	2.10	1.50	0.80	-0.30	0.30	-	-0.30
Other Income / (Expense), net	-0.50	-146	-3.50	0.90	2.70	-0.70	4.80	2.70	3.70	-1.40	-0.90
Income Tax Expense	12	-32	11	13	14	7.50	8.30	7.70	12	20	10
Basic Earnings per Share	$1.31	($2.82)	$1.34	$1.25	$1.66	$1.52	$1.58	$1.16	$1.34	$1.04	$1.56
Weighted Average Basic Shares Outstanding	24.97M	24.93M	24.94M	24.94M	24.89M	24.85M	24.87M	24.87M	24.80M	24.79M	24.79M
Diluted Earnings per Share	$1.31	($2.80)	$1.33	$1.24	$1.65	$1.50	$1.57	$1.16	$1.33	$1.02	$1.55
Weighted Average Diluted Shares Outstanding	25.10M	25.12M	25.10M	25.10M	25.07M	25.02M	25.01M	24.98M	24.96M	24.98M	24.97M
Weighted Average Basic & Diluted Shares Outstanding	24.96M	24.96M	24.94M	24.94M	24.93M	24.87M	24.87M	24.87M	24.87M	24.77M	24.76M

This table details how cash moves in and out of Innospec's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	86	57	5.30	37	30	-47	33	-12	-35	95
Net Cash From Operating Activities	185	207	82	93	146	162	105	83	106	118
Net Cash From Continuing Operating Activities	185	207	82	93	146	162	105	83	106	118
Net Income / (Loss) Continuing Operations	36	139	133	93	29	112	85	62	81	120
Consolidated Net Income / (Loss)	36	139	133	93	29	112	85	62	81	120
Depreciation Expense	44	39	40	43	46	48	50	50	38	35
Non-Cash Adjustments To Reconcile Net Income	160	4.70	4.20	-0.90	24	0.50	0.60	3.20	-1.50	2.60
Changes in Operating Assets and Liabilities, net	-55	24	-96	-42	48	1.30	-30	-33	-12	-39
Net Cash From Investing Activities	-62	-112	-42	-36	-30	-31	-36	-30	-209	15
Net Cash From Continuing Investing Activities	-62	-112	-42	-36	-30	-31	-36	-30	-209	15
Purchase of Property, Plant & Equipment	-62	-77	-42	-39	-30	-31	-30	-28	-17	-26
Acquisitions	-0.20	-35	0.00	0.00	-	-	-5.40	-4.20	-197	0.00
Sale of Property, Plant & Equipment	0.50	0.10	0.20	2.90	0.00	0.00	-	-	-	-
Net Cash From Financing Activities	-35	-39	-34	-20	-87	-178	-36	-66	70	-37
Net Cash From Continuing Financing Activities	-35	-39	-34	-20	-87	-178	-36	-66	70	-37
Repayment of Debt	-0.30	-3.70	-0.10	-0.60	-76	-175	-24	-53	-22	-14
Repurchase of Common Equity	-0.70	-1.10	-5.90	-0.80	-2.10	-2.40	-1.40	-1.10	-8.40	-15
Payment of Dividends	-39	-35	-32	-29	-26	-25	-22	-19	-60	-15
Issuance of Common Equity	4.50	0.90	4.00	10	2.30	1.20	1.10	6.80	2.10	1.30
Effect of Exchange Rate Changes	-1.70	0.10	-0.60	-0.50	0.20	-	-0.30	1.60	-0.90	-1.10

This table details how cash moves in and out of Innospec's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	11	-15	64	-30	66	-3.50	41	18	0.40	47	29
Net Cash From Operating Activities	28	26	74	4.70	81	72	58	55	22	78	40
Net Cash From Continuing Operating Activities	28	26	73	4.80	81	72	58	55	22	78	40
Net Income / (Loss) Continuing Operations	33	-70	33	31	41	38	39	29	33	26	39
Consolidated Net Income / (Loss)	33	-70	33	31	41	38	39	29	33	26	39
Depreciation Expense	11	11	11	11	10	10	9.90	9.90	9.30	9.20	10
Non-Cash Adjustments To Reconcile Net Income	3.10	157	1.10	1.40	1.20	1.30	1.20	1.10	1.10	1.40	0.90
Changes in Operating Assets and Liabilities, net	-19	-71	28	-39	28	23	7.80	15	-22	42	-9.90
Net Cash From Investing Activities	-16	-21	-12	-15	-14	-56	-17	-17	-22	-15	-9.60
Net Cash From Continuing Investing Activities	-16	-21	-12	-15	-14	-56	-17	-17	-22	-15	-9.60
Purchase of Property, Plant & Equipment	-16	-21	-12	-15	-14	-21	-17	-17	-22	-15	-9.70
Sale of Property, Plant & Equipment	0.10	0.20	0.10	0.10	0.10	0.10	-	-	0.00	0.10	-
Net Cash From Financing Activities	-3.80	-18	0.90	-19	0.50	-20	0.20	-19	0.40	-17	-0.40
Net Cash From Continuing Financing Activities	-3.80	-18	0.90	-19	0.50	-20	0.20	-19	0.40	-17	-0.40
Repurchase of Common Equity	-4.80	-	-	-0.30	-0.40	-0.10	-	-0.70	-0.30	-0.90	-2.30
Issuance of Common Equity	1.00	2.00	0.90	0.70	0.90	-0.10	0.10	0.20	0.70	-	1.90
Effect of Exchange Rate Changes	1.60	-1.90	0.90	-0.30	-0.40	0.30	-0.30	-0.10	0.20	0.30	-0.70

This table presents Innospec's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	1,735	1,707	1,604	1,571	1,397	1,469	1,473	1,410	1,181	1,029
Total Current Assets	957	886	873	728	566	630	664	0.00	441	459
Cash & Equivalents	289	204	147	142	105	76	123	-	102	137
Accounts Receivable	342	360	335	285	221	292	280	-	154	137
Inventories, net	301	300	373	278	220	245	248	-	174	160
Prepaid Expenses	21	19	14	18	15	15	12	-	6.20	6.10
Current Deferred & Refundable Income Taxes	3.10	2.80	3.30	5.80	4.20	2.50	1.50	-	4.80	12
Other Current Assets	0.60	0.60	0.40	0.40	0.40	0.80	0.00	-	0.00	1.80
Plant, Property, & Equipment, net	270	268	221	214	211	199	196	0.00	157	76
Total Noncurrent Assets	508	553	510	628	620	640	613	362	583	494
Goodwill	383	399	359	364	371	363	365	362	375	267
Intangible Assets	65	57	45	58	75	114	136	-	144	169
Noncurrent Deferred & Refundable Income Taxes	9.40	10	5.90	6.40	7.60	9.10	8.80	-	15	1.40
Employee Benefit Assets	2.40	35	48	160	118	116	96	-	48	56
Other Noncurrent Operating Assets	49	51	52	40	48	38	7.20	-	0.80	0.90
Total Liabilities & Shareholders' Equity	1,735	1,707	1,604	1,571	1,397	1,469	1,473	843	1,181	1,029
Total Liabilities	519	558	563	538	453	550	648	49	528	423
Total Current Liabilities	371	372	406	337	252	304	297	5.20	183	206
Accounts Payable	164	164	165	149	99	122	127	-	60	52
Accrued Expenses	169	186	203	167	130	154	132	-	95	84
Current Deferred & Payable Income Tax Liabilities	20	3.80	18	3.70	5.50	10	8.60	-	9.40	7.90
Other Current Liabilities	19	18	19	18	18	16	5.90	5.20	6.70	6.40
Total Noncurrent Liabilities	147	186	158	201	200	246	351	43	345	217
Asset Retirement Reserve & Litigation Obligation	55	57	52	51	52	44	44	41	33	31
Noncurrent Deferred Revenue	0.00	12	21	31	32	36	40	-	0.50	0.60
Noncurrent Deferred & Payable Income Tax Liabilities	24	47	40	77	63	66	62	2.50	35	42
Noncurrent Employee Benefit Liabilities	13	13	12	18	21	18	16	-	14	9.20
Other Noncurrent Operating Liabilities	55	57	33	25	3.50	24	2.10	-	1.00	0.50
Total Equity & Noncontrolling Interests	1,216	1,150	1,040	1,033	945	919	826	794	654	605
Total Preferred & Common Equity	1,211	1,147	1,038	1,032	944	919	825	794	654	605
Total Common Equity	1,211	1,147	1,038	1,032	944	919	825	794	654	605
Common Stock	370	361	354	347	336	331	325	794	315	311
Retained Earnings	1,025	1,028	924	823	759	756	668	-	562	496
Treasury Stock	-93	-94	-95	-91	-93	-93	-93	-	-98	-92
Accumulated Other Comprehensive Income / (Loss)	-91	-148	-145	-47	-57	-74	-76	-	-126	-111
Noncontrolling Interest	4.90	2.50	2.40	0.60	0.50	0.40	0.50	-	0.30	0.30

This table presents Innospec's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,775	1,798	1,700	1,733	1,619	1,611	1,624	1,669
Total Current Assets	977	966	877	913	864	855	875	846
Cash & Equivalents	300	304	240	270	207	166	148	101
Accounts Receivable	344	328	300	318	305	311	342	343
Inventories, net	315	319	314	304	332	357	366	382
Prepaid Expenses	16	9.20	9.70	15	7.70	11	15	7.40
Current Deferred & Refundable Income Taxes	1.00	5.10	12	4.40	11	9.80	3.60	14
Other Current Assets	1.40	0.60	1.00	0.90	1.40	0.70	0.40	0.40
Plant, Property, & Equipment, net	277	278	272	269	245	242	234	207
Total Noncurrent Assets	520	554	552	551	510	514	516	616
Goodwill	388	392	388	398	358	361	360	352
Intangible Assets	73	64	61	58	48	47	47	44
Noncurrent Deferred & Refundable Income Taxes	8.60	11	10	10	5.90	5.90	5.90	5.70
Employee Benefit Assets	1.20	38	37	36	50	49	49	163
Other Noncurrent Operating Assets	49	49	55	50	49	52	54	53
Total Liabilities & Shareholders' Equity	1,775	1,798	1,700	1,733	1,619	1,611	1,624	1,669
Total Liabilities	509	550	504	547	491	516	544	577
Total Current Liabilities	358	373	333	365	344	365	382	381
Accounts Payable	170	169	148	166	146	158	178	174
Accrued Expenses	148	170	143	164	165	175	164	174
Current Deferred & Payable Income Tax Liabilities	22	16	23	17	15	14	20	15
Other Current Liabilities	19	19	20	18	18	19	20	19
Total Noncurrent Liabilities	151	177	172	182	146	151	162	196
Asset Retirement Reserve & Litigation Obligation	57	59	57	57	51	53	52	50
Noncurrent Deferred & Payable Income Tax Liabilities	23	47	46	45	41	41	41	76
Noncurrent Employee Benefit Liabilities	13	13	13	13	12	12	13	16
Other Noncurrent Operating Liabilities	58	58	56	56	31	33	35	34
Total Equity & Noncontrolling Interests	1,266	1,248	1,196	1,186	1,128	1,095	1,081	1,092
Total Preferred & Common Equity	1,260	1,243	1,193	1,184	1,125	1,092	1,078	1,089
Total Common Equity	1,260	1,243	1,193	1,184	1,125	1,092	1,078	1,089
Common Stock	371	367	365	363	359	357	355	353
Retained Earnings	1,058	1,115	1,082	1,070	1,008	969	957	915
Treasury Stock	-97	-93	-93	-93	-94	-94	-94	-95
Accumulated Other Comprehensive Income / (Loss)	-72	-145	-161	-155	-148	-140	-141	-83
Noncontrolling Interest	5.70	4.20	3.30	2.60	2.70	2.60	2.40	2.50

This table displays calculated financial ratios and metrics derived from Innospec's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.31%	-0.76%	32.38%	24.33%	-21.16%	2.46%	13.02%	47.93%	-12.73%	5.35%
EBITDA Growth	-64.33%	-6.38%	26.43%	104.11%	-56.85%	7.82%	0.75%	29.29%	-24.60%	33.54%
EBIT Growth	-81.46%	-7.32%	36.64%	227.47%	-73.26%	12.06%	1.61%	28.22%	-31.99%	36.75%
NOPAT Growth	19.26%	-4.49%	47.47%	275.61%	-78.21%	29.69%	42.99%	-22.12%	-36.86%	43.75%
Net Income Growth	-74.41%	4.59%	42.86%	224.39%	-74.42%	32.00%	37.54%	-23.99%	-31.97%	42.09%
EPS Growth	-74.46%	4.51%	41.87%	223.28%	-74.45%	31.59%	36.90%	-24.32%	-31.48%	43.79%
Operating Cash Flow Growth	-11.00%	153.73%	-12.34%	-36.12%	-9.72%	54.05%	26.84%	-21.61%	-10.74%	11.19%
Free Cash Flow Firm Growth	126.40%	-42.57%	93.07%	16.30%	-51.44%	123.71%	-189.79%	703.29%	67.78%	-24,714.42%
Invested Capital Growth	-2.01%	5.89%	0.24%	2.61%	-3.85%	-1.09%	191.60%	-62.05%	26.39%	176.89%
Revenue Q/Q Growth	-1.49%	-0.81%	5.22%	4.93%	-3.81%	-0.28%	2.87%	9.74%	-0.92%	-4.23%
EBITDA Q/Q Growth	-66.26%	-0.19%	4.39%	-4.70%	-1.80%	0.00%	0.00%	9.18%	-4.12%	-2.94%
EBIT Q/Q Growth	-82.35%	-0.81%	6.97%	-6.79%	-2.35%	0.26%	1.09%	9.74%	-5.60%	-4.46%
NOPAT Q/Q Growth	11.50%	8.23%	0.31%	-6.27%	1.35%	10.25%	46.45%	-29.60%	-13.11%	1.86%
Net Income Q/Q Growth	-75.24%	9.70%	1.22%	-8.28%	4.36%	10.54%	42.14%	-30.33%	-10.36%	3.11%
EPS Q/Q Growth	-75.17%	9.45%	0.95%	-8.76%	7.41%	10.46%	41.39%	-30.39%	-10.24%	3.85%
Operating Cash Flow Q/Q Growth	-20.20%	-2.81%	13.31%	12.83%	-0.14%	-6.59%	27.00%	54.00%	-7.94%	-14.29%
Free Cash Flow Firm Q/Q Growth	50.23%	-59.76%	182.47%	28.06%	-14.18%	-29.63%	-58,588.86%	390.16%	-215.65%	-811.55%
Invested Capital Q/Q Growth	-1.79%	2.71%	-9.90%	-1.41%	0.99%	-0.18%	-6.48%	-65.90%	29.81%	3.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.42%	30.33%	29.88%	29.32%	28.72%	30.81%	29.45%	30.86%	37.62%	34.18%
EBITDA Margin	4.09%	10.85%	11.50%	12.04%	7.33%	13.40%	12.74%	14.29%	16.35%	18.92%
Operating Margin	9.64%	8.29%	9.54%	8.91%	2.82%	9.91%	9.04%	9.57%	11.12%	15.44%
EBIT Margin	1.73%	8.83%	9.46%	9.16%	3.48%	10.26%	9.38%	10.43%	12.03%	15.44%
Profit (Net Income) Margin	1.93%	7.14%	6.77%	6.28%	2.41%	7.41%	5.76%	4.73%	9.20%	11.80%
Tax Burden Percent	86.41%	79.76%	72.05%	69.27%	72.29%	74.60%	64.59%	48.24%	78.86%	78.46%
Interest Burden Percent	129.15%	101.34%	99.41%	98.90%	95.66%	96.91%	95.02%	93.98%	96.99%	97.44%
Effective Tax Rate	13.59%	20.24%	27.95%	30.73%	27.71%	25.40%	35.41%	51.76%	21.14%	21.54%
Return on Invested Capital (ROIC)	16.42%	14.02%	15.12%	10.40%	2.75%	12.31%	14.06%	10.59%	10.48%	27.60%
ROIC Less NNEP Spread (ROIC-NNEP)	64.34%	8.20%	16.47%	8.94%	-6.68%	13.34%	14.68%	9.63%	14.01%	30.30%
Return on Net Nonoperating Assets (RNNOA)	-13.41%	-1.31%	-2.30%	-0.99%	0.33%	0.55%	-3.57%	-2.06%	2.44%	-6.28%
Return on Equity (ROE)	3.01%	12.70%	12.83%	9.41%	3.08%	12.86%	10.50%	8.54%	12.91%	21.32%
Cash Return on Invested Capital (CROIC)	18.45%	8.30%	14.89%	7.82%	6.68%	13.41%	-83.80%	100.55%	-12.84%	-66.27%
Operating Return on Assets (OROA)	1.85%	10.40%	11.70%	9.16%	2.90%	10.55%	9.61%	10.52%	9.62%	15.41%
Return on Assets (ROA)	2.07%	8.40%	8.38%	6.27%	2.00%	7.63%	5.90%	4.77%	7.36%	11.78%
Return on Common Equity (ROCE)	3.00%	12.67%	12.81%	9.41%	3.08%	12.86%	10.49%	8.53%	12.91%	9.48%
Return on Equity Simple (ROE_SIMPLE)	2.94%	12.13%	12.81%	9.02%	3.04%	12.22%	10.30%	7.78%	12.44%	19.75%
Net Operating Profit after Tax (NOPAT)	154	129	135	92	24	112	86	60	77	123
NOPAT Margin	8.33%	6.61%	6.87%	6.17%	2.04%	7.39%	5.84%	4.61%	8.77%	12.11%
Net Nonoperating Expense Percent (NNEP)	-47.93%	5.82%	-1.35%	1.46%	9.43%	-1.03%	-0.62%	0.97%	-3.53%	-2.70%
Return On Investment Capital (ROIC_SIMPLE)	12.64%	11.21%	12.97%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	70.58%	69.67%	70.12%	70.68%	71.28%	69.19%	70.55%	69.14%	62.38%	65.82%
SG&A Expenses to Revenue	17.02%	19.90%	18.37%	18.01%	19.86%	18.56%	17.67%	18.69%	24.53%	20.42%
R&D to Revenue	2.59%	2.14%	1.97%	2.52%	2.59%	2.34%	2.26%	2.40%	2.88%	2.50%
Operating Expenses to Revenue	19.78%	22.04%	20.34%	20.41%	25.90%	20.90%	20.41%	21.30%	26.50%	18.74%
Earnings before Interest and Taxes (EBIT)	32	172	186	136	42	155	139	136	106	156
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	75	211	226	179	88	203	188	187	144	192
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.27	2.64	2.39	2.09	2.26	2.60	1.71	1.98	2.29	1.94
Price to Tangible Book Value (P/TBV)	3.60	4.38	3.91	3.53	4.29	5.41	4.35	3.63	11.14	6.97
Price to Revenue (P/Rev)	1.49	1.55	1.26	1.45	1.79	1.58	0.95	1.20	1.69	1.16
Price to Earnings (P/E)	77.11	21.76	18.66	23.17	74.39	21.31	16.55	25.42	18.40	9.84
Dividend Yield	1.41%	1.16%	1.28%	1.33%	1.20%	1.05%	1.55%	1.18%	1.07%	1.25%
Earnings Yield	1.30%	4.60%	5.36%	4.32%	1.34%	4.69%	6.04%	3.93%	5.43%	10.16%
Enterprise Value to Invested Capital (EV/IC)	2.65	2.99	2.62	2.26	2.37	2.63	1.64	5.02	2.02	1.88
Enterprise Value to Revenue (EV/Rev)	1.33	1.45	1.19	1.36	1.73	1.57	1.01	1.20	1.89	1.21
Enterprise Value to EBITDA (EV/EBITDA)	32.64	13.36	10.35	11.29	23.53	11.71	7.95	8.41	11.55	6.39
Enterprise Value to EBIT (EV/EBIT)	77.14	16.42	12.58	14.84	49.62	15.31	10.80	11.52	15.69	7.83
Enterprise Value to NOPAT (EV/NOPAT)	16.01	21.92	17.32	22.03	84.52	21.24	17.34	26.05	21.54	9.98
Enterprise Value to Operating Cash Flow (EV/OCF)	13.34	13.63	28.60	21.63	14.11	14.70	14.25	18.99	15.81	10.36
Enterprise Value to Free Cash Flow (EV/FCFF)	14.25	37.03	17.59	29.30	34.81	19.50	0.00	2.74	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.03	0.07	0.26	0.00	0.42	0.31
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.03	0.06	0.23	0.00	0.40	0.22
Financial Leverage	-0.21	-0.16	-0.14	-0.11	-0.05	0.04	-0.24	-0.21	0.17	-0.21
Leverage Ratio	1.46	1.51	1.53	1.50	1.54	1.69	1.78	1.79	1.76	1.81
Compound Leverage Factor	1.88	1.53	1.52	1.48	1.47	1.63	1.69	1.68	1.70	1.76
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	2.97%	6.14%	20.35%	0.00%	29.48%	23.82%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.10%	2.24%	0.00%	1.28%	6.96%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	2.97%	6.04%	18.11%	0.00%	28.20%	16.86%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.40%	0.22%	0.23%	0.06%	0.05%	0.04%	0.05%	0.00%	0.03%	0.04%
Common Equity to Total Capital	99.60%	99.78%	99.77%	99.94%	96.98%	93.82%	79.60%	100.00%	70.49%	76.14%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.33	0.30	1.12	0.00	1.89	0.99
Net Debt to EBITDA	0.00	0.00	0.00	0.00	-0.87	-0.08	0.47	0.00	1.19	0.25
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.33	0.29	1.00	0.00	1.81	0.70
Debt to NOPAT	0.00	0.00	0.00	0.00	1.19	0.54	2.45	0.00	3.53	1.54
Net Debt to NOPAT	0.00	0.00	0.00	0.00	-3.14	-0.14	1.02	0.00	2.21	0.39
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	1.19	0.53	2.18	0.00	3.38	1.09
Altman Z-Score	5.53	5.93	5.41	4.67	4.81	4.97	3.55	20.63	3.67	4.12
Noncontrolling Interest Sharing Ratio	0.31%	0.22%	0.14%	0.06%	0.05%	0.05%	0.03%	0.02%	0.05%	55.52%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.58	2.38	2.15	2.16	2.24	2.08	2.24	0.00	2.41	2.23
Quick Ratio	1.70	1.52	1.19	1.27	1.29	1.21	1.36	0.00	1.40	1.35
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	173	76	133	69	59	122	-514	572	-95	-294
Operating Cash Flow to CapEx	298.54%	268.87%	194.06%	257.46%	491.25%	521.29%	348.51%	295.36%	639.39%	451.15%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.07	1.18	1.24	1.00	0.83	1.03	1.02	1.01	0.80	1.00
Accounts Receivable Turnover	5.26	5.61	6.34	5.86	4.65	5.29	0.00	0.00	6.05	0.00
Inventory Turnover	4.33	4.03	4.23	4.21	3.66	4.25	0.00	0.00	3.30	0.00
Fixed Asset Turnover	6.86	7.97	9.02	6.98	5.83	7.66	0.00	0.00	7.57	0.00
Accounts Payable Turnover	7.96	8.26	8.77	8.48	7.71	8.42	0.00	0.00	9.86	0.00
Days Sales Outstanding (DSO)	69.37	65.03	57.54	62.24	78.53	68.95	0.00	0.00	60.28	0.00
Days Inventory Outstanding (DIO)	84.22	90.49	86.24	86.61	99.71	85.86	0.00	0.00	110.51	0.00
Days Payable Outstanding (DPO)	45.87	44.21	41.62	43.06	47.36	43.36	0.00	0.00	37.02	0.00
Cash Conversion Cycle (CCC)	107.72	111.31	102.16	105.79	130.87	111.44	0.00	0.00	133.77	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	927	946	893	891	869	903	913	313	825	653
Invested Capital Turnover	1.97	2.12	2.20	1.69	1.35	1.67	2.41	2.30	1.20	2.28
Increase / (Decrease) in Invested Capital	-19	53	2.10	23	-35	-10	600	-512	172	417
Enterprise Value (EV)	2,461	2,825	2,337	2,016	2,059	2,376	1,495	1,571	1,668	1,224
Market Capitalization	2,745	3,026	2,482	2,157	2,135	2,391	1,407	1,571	1,496	1,176
Book Value per Share	$48.56	$46.13	$41.91	$41.89	$38.42	$37.50	$33.78	$32.91	$27.25	$25.12
Tangible Book Value per Share	$30.60	$27.77	$25.61	$24.77	$20.26	$18.04	$13.26	$17.92	$5.60	$7.01
Total Capital	1,216	1,150	1,040	1,033	974	979	1,036	794	927	795
Total Debt	0.00	0.00	0.00	0.00	29	60	211	0.00	273	189
Total Long-Term Debt	0.00	0.00	0.00	0.00	29	59	188	0.00	261	134
Net Debt	-289	-204	-147	-142	-76	-16	88	0.00	171	48
Capital Expenditures (CapEx)	62	77	42	36	30	31	30	28	17	26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	296	311	320	250	209	252	267	-5.20	168	166
Debt-free Net Working Capital (DFNWC)	585	514	467	392	314	328	391	-5.20	270	308
Net Working Capital (NWC)	585	514	467	392	314	327	367	-5.20	258	253
Net Nonoperating Expense (NNE)	118	-10	1.95	-1.59	-4.34	-0.37	1.23	-1.50	-3.86	3.14
Net Nonoperating Obligations (NNO)	-289	-204	-147	-142	-76	-16	88	-481	171	48
Total Depreciation and Amortization (D&A)	44	39	40	43	46	48	50	50	38	35
Debt-free, Cash-free Net Working Capital to Revenue	16.04%	15.93%	16.28%	16.83%	17.48%	16.66%	18.11%	-0.40%	19.02%	16.42%
Debt-free Net Working Capital to Revenue	31.71%	26.39%	23.77%	26.39%	26.30%	21.66%	26.44%	-0.40%	30.55%	30.42%
Net Working Capital to Revenue	31.71%	26.39%	23.77%	26.39%	26.30%	21.60%	24.87%	-0.40%	29.21%	24.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.43	$5.60	$5.37	$3.78	$1.17	$4.58	$3.48	$2.56	$3.39	$4.96
Adjusted Weighted Average Basic Shares Outstanding	24.93M	24.85M	24.79M	24.65M	24.56M	24.48M	24.40M	24.15M	24.00M	24.11M
Adjusted Diluted Earnings per Share	$1.42	$5.56	$5.32	$3.75	$1.16	$4.54	$3.45	$2.52	$3.33	$4.86
Adjusted Weighted Average Diluted Shares Outstanding	25.12M	25.02M	24.98M	24.85M	24.78M	24.73M	24.60M	24.49M	24.44M	24.61M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.96M	24.87M	24.77M	24.77M	24.60M	24.51M	24.43M	24.35M	24.07M	24.01M
Normalized Net Operating Profit after Tax (NOPAT)	156	129	135	90	54	112	91	88	70	91
Normalized NOPAT Margin	8.48%	6.61%	6.87%	6.08%	4.53%	7.39%	6.15%	6.70%	7.93%	8.96%
Pre Tax Income Margin	2.23%	8.95%	9.40%	9.06%	3.33%	9.94%	8.91%	9.80%	11.67%	15.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	108.99%	25.23%	23.83%	30.93%	89.20%	22.28%	25.53%	30.10%	73.68%	12.47%
Augmented Payout Ratio	110.96%	26.02%	28.27%	31.79%	96.52%	24.42%	27.18%	31.88%	84.01%	25.27%

This table displays calculated financial ratios and metrics derived from Innospec's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-11.88%	-5.64%	-4.46%	-9.45%	-1.84%	-3.13%	-9.53%	2.74%	7.87%	23.60%	36.40%
EBITDA Growth	-16.82%	-274.26%	-6.01%	12.61%	17.78%	-0.74%	-4.55%	-11.70%	-8.63%	21.16%	42.89%
EBIT Growth	-21.05%	-339.73%	-9.85%	12.74%	19.02%	-3.10%	-5.08%	-13.58%	-8.02%	36.56%	57.69%
NOPAT Growth	-16.96%	-22.52%	-1.68%	7.60%	24.98%	41.24%	-12.79%	-23.62%	-9.83%	1.32%	66.21%
Net Income Growth	-20.77%	-286.24%	-14.80%	7.96%	24.70%	48.24%	1.29%	-10.53%	-9.04%	6.69%	65.38%
EPS Growth	-20.61%	-286.67%	-15.29%	6.90%	24.06%	47.06%	1.29%	-10.08%	-8.90%	5.15%	64.89%
Operating Cash Flow Growth	-64.89%	-64.50%	26.51%	-91.45%	269.72%	-7.65%	45.98%	833.33%	175.17%	13.95%	1,321.43%
Free Cash Flow Firm Growth	-133.58%	408.84%	-89.44%	-97.63%	-38.25%	-163.94%	319.60%	216.44%	109.26%	645.11%	-138.72%
Invested Capital Growth	5.44%	-2.01%	2.49%	2.89%	-1.82%	5.89%	-7.11%	-6.85%	-5.90%	0.24%	9.68%
Revenue Q/Q Growth	-5.57%	5.28%	1.93%	-13.03%	1.11%	6.59%	-3.39%	-5.73%	-0.22%	-0.45%	9.71%
EBITDA Q/Q Growth	156.22%	-276.88%	0.95%	-17.14%	17.78%	-4.59%	20.94%	-13.33%	-0.74%	-8.26%	11.89%
EBIT Q/Q Growth	140.00%	-349.41%	1.20%	-21.80%	21.46%	-6.21%	26.56%	-17.45%	-1.11%	-8.13%	15.22%
NOPAT Q/Q Growth	9.13%	-15.37%	16.99%	-23.14%	1.82%	7.39%	28.05%	-10.72%	15.06%	-33.69%	12.15%
Net Income Q/Q Growth	146.59%	-310.78%	7.05%	-24.64%	9.52%	-3.57%	35.64%	-12.95%	30.20%	-34.11%	19.81%
EPS Q/Q Growth	146.79%	-310.53%	7.26%	-24.85%	10.00%	-4.46%	35.34%	-12.78%	30.39%	-34.19%	20.16%
Operating Cash Flow Q/Q Growth	10.12%	-65.03%	1,463.83%	-94.17%	11.33%	24.61%	5.64%	152.29%	-72.19%	96.98%	630.67%
Free Cash Flow Firm Q/Q Growth	-138.53%	330.50%	391.40%	-95.88%	454.33%	-114.72%	10.26%	7.39%	266.89%	150.55%	41.54%
Invested Capital Q/Q Growth	4.21%	-1.79%	-1.25%	4.32%	-3.15%	2.71%	-0.86%	-0.45%	4.46%	-9.90%	-0.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.38%	29.18%	27.99%	29.17%	31.13%	31.47%	29.56%	31.31%	29.00%	29.68%	30.41%
EBITDA Margin	12.00%	-20.16%	12.00%	12.11%	12.71%	10.92%	12.20%	9.74%	10.60%	10.65%	11.56%
Operating Margin	9.64%	8.80%	10.28%	9.36%	10.10%	9.00%	9.03%	7.12%	8.05%	9.12%	9.77%
EBIT Margin	9.53%	-22.49%	9.49%	9.56%	10.64%	8.85%	10.06%	7.68%	8.77%	8.85%	9.59%
Profit (Net Income) Margin	7.44%	-15.08%	7.53%	7.17%	8.28%	7.64%	8.45%	6.02%	6.51%	4.99%	7.54%
Tax Burden Percent	73.87%	68.62%	74.55%	71.40%	74.86%	83.44%	82.53%	78.96%	73.78%	56.42%	79.14%
Interest Burden Percent	105.71%	97.71%	106.41%	105.05%	103.95%	103.42%	101.71%	99.19%	100.67%	100.00%	99.39%
Effective Tax Rate	26.13%	0.00%	25.45%	28.60%	25.14%	16.56%	17.47%	21.04%	26.22%	43.58%	20.86%
Return on Invested Capital (ROIC)	13.52%	12.15%	15.41%	13.43%	15.85%	15.91%	15.31%	11.75%	12.34%	11.33%	15.22%
ROIC Less NNEP Spread (ROIC-NNEP)	13.03%	52.39%	15.64%	12.37%	14.13%	15.53%	12.31%	10.16%	9.72%	11.88%	16.22%
Return on Net Nonoperating Assets (RNNOA)	-3.03%	-10.91%	-3.36%	-2.19%	-2.60%	-2.49%	-1.71%	-1.11%	-1.02%	-1.65%	-1.48%
Return on Equity (ROE)	10.49%	1.23%	12.04%	11.23%	13.25%	13.42%	13.60%	10.64%	11.33%	9.67%	13.74%
Cash Return on Invested Capital (CROIC)	10.80%	18.45%	12.33%	11.86%	16.60%	8.30%	19.83%	19.92%	19.75%	14.89%	4.96%
Operating Return on Assets (OROA)	9.70%	-24.12%	10.41%	10.94%	12.29%	10.42%	12.03%	9.52%	10.81%	10.95%	11.32%
Return on Assets (ROA)	7.58%	-16.17%	8.26%	8.21%	9.56%	8.99%	10.10%	7.46%	8.03%	6.18%	8.91%
Return on Common Equity (ROCE)	10.46%	1.23%	12.01%	11.20%	13.22%	13.39%	13.57%	10.62%	11.31%	9.66%	13.72%
Return on Equity Simple (ROE_SIMPLE)	2.14%	0.00%	11.57%	12.54%	12.45%	0.00%	11.27%	11.56%	12.03%	0.00%	12.06%
Net Operating Profit after Tax (NOPAT)	31	29	34	29	38	37	35	27	30	26	40
NOPAT Margin	7.12%	6.16%	7.67%	6.68%	7.56%	7.51%	7.45%	5.62%	5.94%	5.15%	7.73%
Net Nonoperating Expense Percent (NNEP)	0.49%	-40.24%	-0.23%	1.05%	1.72%	0.38%	3.00%	1.60%	2.63%	-0.55%	-1.00%
Return On Investment Capital (ROIC_SIMPLE)	2.48%	2.37%	-	-	-	3.23%	-	-	-	2.53%	-
Cost of Revenue to Revenue	71.62%	70.82%	72.01%	70.83%	68.87%	68.53%	70.44%	68.69%	71.00%	70.32%	69.59%
SG&A Expenses to Revenue	15.72%	17.37%	15.07%	16.87%	18.53%	20.68%	18.03%	21.98%	18.88%	18.92%	18.67%
R&D to Revenue	2.88%	2.72%	2.50%	2.80%	2.36%	1.80%	2.50%	2.21%	2.08%	1.64%	1.97%
Operating Expenses to Revenue	18.74%	20.37%	17.70%	19.82%	21.03%	22.48%	20.53%	24.19%	20.96%	20.56%	20.64%
Earnings before Interest and Taxes (EBIT)	42	-105	42	42	53	44	47	37	45	45	49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	53	-94	53	53	64	54	57	47	54	54	59
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.88	2.27	2.27	2.58	2.69	2.64	2.23	2.26	2.31	2.39	1.90
Price to Tangible Book Value (P/TBV)	2.96	3.60	3.58	4.15	4.38	4.38	3.49	3.60	3.72	3.91	2.98
Price to Revenue (P/Rev)	1.32	1.49	1.51	1.63	1.64	1.55	1.28	1.23	1.25	1.26	1.11
Price to Earnings (P/E)	87.59	77.11	19.61	20.60	21.64	21.76	19.79	19.53	19.23	18.66	15.76
Dividend Yield	1.64%	1.41%	1.31%	1.20%	1.10%	1.16%	1.33%	1.35%	1.27%	1.28%	1.46%
Earnings Yield	1.14%	1.30%	5.10%	4.85%	4.62%	4.60%	5.05%	5.12%	5.20%	5.36%	6.35%
Enterprise Value to Invested Capital (EV/IC)	2.14	2.65	2.67	2.98	3.19	2.99	2.50	2.48	2.52	2.62	1.99
Enterprise Value to Revenue (EV/Rev)	1.16	1.33	1.35	1.50	1.51	1.45	1.17	1.14	1.17	1.19	1.06
Enterprise Value to EBITDA (EV/EBITDA)	32.01	32.64	11.28	12.54	13.21	13.36	10.88	10.74	10.64	10.35	9.12
Enterprise Value to EBIT (EV/EBIT)	100.04	77.14	13.95	15.35	16.17	16.42	13.29	13.09	12.92	12.58	11.36
Enterprise Value to NOPAT (EV/NOPAT)	13.68	16.01	18.29	20.54	21.40	21.92	19.36	18.64	17.85	17.32	14.66
Enterprise Value to Operating Cash Flow (EV/OCF)	15.66	13.34	10.90	13.18	10.97	13.63	10.81	11.81	17.72	28.60	27.36
Enterprise Value to Free Cash Flow (EV/FCFF)	20.38	14.25	21.93	25.46	19.03	37.03	12.16	12.01	12.36	17.59	41.94
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.23	-0.21	-0.22	-0.18	-0.18	-0.16	-0.14	-0.11	-0.10	-0.14	-0.09
Leverage Ratio	1.43	1.46	1.44	1.45	1.48	1.51	1.48	1.50	1.51	1.53	1.52
Compound Leverage Factor	1.51	1.42	1.53	1.52	1.54	1.56	1.51	1.49	1.52	1.53	1.51
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.45%	0.40%	0.34%	0.28%	0.22%	0.22%	0.24%	0.24%	0.22%	0.23%	0.23%
Common Equity to Total Capital	99.55%	99.60%	99.66%	99.72%	99.78%	99.78%	99.76%	99.76%	99.78%	99.77%	99.77%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.13	5.27	5.46	6.13	5.96	5.69	5.64	5.40	5.27	5.12	4.47
Noncontrolling Interest Sharing Ratio	0.34%	0.31%	0.29%	0.26%	0.22%	0.22%	0.23%	0.15%	0.14%	0.14%	0.15%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.73	2.58	2.59	2.63	2.50	2.38	2.51	2.34	2.29	2.15	2.22
Quick Ratio	1.80	1.70	1.69	1.62	1.61	1.52	1.49	1.31	1.28	1.19	1.16
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-18	48	11	2.26	55	-15	105	95	89	24	-48
Operating Cash Flow to CapEx	182.58%	124.76%	628.21%	30.92%	563.64%	343.13%	347.90%	317.92%	99.09%	519.21%	410.31%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.02	1.07	1.10	1.14	1.16	1.18	1.20	1.24	1.23	1.24	1.18
Accounts Receivable Turnover	5.40	5.26	5.92	6.20	5.87	5.61	6.07	6.19	5.88	6.34	5.78
Inventory Turnover	4.11	4.33	4.03	3.93	4.00	4.03	3.86	3.92	4.17	4.23	4.02
Fixed Asset Turnover	6.54	6.86	7.17	7.37	7.72	7.97	8.71	8.91	8.95	9.02	8.90
Accounts Payable Turnover	7.58	7.96	8.32	8.63	7.79	8.26	8.62	8.31	8.28	8.77	8.49
Days Sales Outstanding (DSO)	67.61	69.37	61.65	58.89	62.16	65.03	60.16	58.98	62.03	57.54	63.11
Days Inventory Outstanding (DIO)	88.79	84.22	90.60	92.77	91.22	90.49	94.48	93.19	87.49	86.24	90.81
Days Payable Outstanding (DPO)	48.13	45.87	43.87	42.30	46.85	44.21	42.35	43.92	44.08	41.62	43.02
Cash Conversion Cycle (CCC)	108.28	107.72	108.38	109.36	106.54	111.31	112.30	108.25	105.45	102.16	110.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	966	927	944	956	916	946	921	929	933	893	991
Invested Capital Turnover	1.90	1.97	2.01	2.01	2.10	2.12	2.05	2.09	2.08	2.20	1.97
Increase / (Decrease) in Invested Capital	50	-19	23	27	-17	53	-71	-68	-59	2.10	88
Enterprise Value (EV)	2,071	2,461	2,521	2,845	2,920	2,825	2,305	2,304	2,348	2,337	1,973
Market Capitalization	2,365	2,745	2,821	3,081	3,187	3,026	2,510	2,467	2,494	2,482	2,071
Book Value per Share	$50.48	$48.56	$49.85	$47.83	$47.55	$46.13	$45.26	$43.92	$43.54	$41.91	$43.94
Tangible Book Value per Share	$32.00	$30.60	$31.57	$29.80	$29.26	$27.77	$28.94	$27.54	$27.10	$25.61	$28.00
Total Capital	1,266	1,216	1,248	1,196	1,186	1,150	1,128	1,095	1,081	1,040	1,092
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-300	-289	-304	-240	-270	-204	-207	-166	-148	-147	-101
Capital Expenditures (CapEx)	16	21	12	15	14	21	17	17	22	15	9.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)	320	296	289	304	278	311	312	324	346	320	365
Debt-free Net Working Capital (DFNWC)	620	585	593	544	548	514	520	490	493	467	465
Net Working Capital (NWC)	620	585	593	544	548	514	520	490	493	467	465
Net Nonoperating Expense (NNE)	-1.40	99	0.60	-2.14	-3.59	-0.67	-4.62	-1.90	-2.95	0.79	0.95
Net Nonoperating Obligations (NNO)	-300	-289	-304	-240	-270	-204	-207	-166	-148	-147	-101
Total Depreciation and Amortization (D&A)	11	11	11	11	10	10	9.90	9.90	9.30	9.20	10
Debt-free, Cash-free Net Working Capital to Revenue	17.90%	16.04%	15.41%	16.04%	14.33%	15.93%	15.89%	16.07%	17.29%	16.28%	19.53%
Debt-free Net Working Capital to Revenue	34.69%	31.71%	31.63%	28.72%	28.26%	26.39%	26.44%	24.31%	24.66%	23.77%	24.92%
Net Working Capital to Revenue	34.69%	31.71%	31.63%	28.72%	28.26%	26.39%	26.44%	24.31%	24.66%	23.77%	24.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.31	($2.82)	$1.34	$1.25	$1.66	$1.52	$1.58	$1.16	$1.34	$1.04	$1.56
Adjusted Weighted Average Basic Shares Outstanding	24.97M	24.93M	24.94M	24.94M	24.89M	24.85M	24.87M	24.87M	24.80M	24.79M	24.79M
Adjusted Diluted Earnings per Share	$1.31	($2.80)	$1.33	$1.24	$1.65	$1.50	$1.57	$1.16	$1.33	$1.02	$1.55
Adjusted Weighted Average Diluted Shares Outstanding	25.10M	25.12M	25.10M	25.10M	25.07M	25.02M	25.01M	24.98M	24.96M	24.98M	24.97M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	24.96M	24.96M	24.94M	24.94M	24.93M	24.87M	24.87M	24.87M	24.87M	24.77M	24.76M
Normalized Net Operating Profit after Tax (NOPAT)	32	30	34	29	38	37	35	27	30	26	40
Normalized NOPAT Margin	7.22%	6.36%	7.77%	6.78%	7.66%	7.51%	7.45%	5.62%	5.94%	5.15%	7.73%
Pre Tax Income Margin	10.07%	-21.98%	10.10%	10.05%	11.06%	9.16%	10.23%	7.62%	8.83%	8.85%	9.53%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	108.99%	25.66%	24.67%	0.00%	25.23%	26.26%	26.37%	0.00%	23.83%	23.14%
Augmented Payout Ratio	18.89%	110.96%	26.22%	25.20%	0.81%	26.02%	27.76%	29.69%	4.09%	28.27%	26.94%

Frequently Asked Questions About Innospec's Financials

When does Innospec's financial year end?

According to the most recent income statement we have on file, Innospec's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Innospec's net income changed over the last 9 years?

The last 5 years of Innospec's net income performance:

2020: $28.70 million
2021: $93.10 million
2022: $133 million
2023: $139.10 million
2024: $35.60 million

Find out what analysts predict for Innospec in the coming months.

What is Innospec's operating income?

Innospec's total operating income in 2024 was $177.90 million, based on the following breakdown:

Total Gross Profit: $542.90 million
Total Operating Expenses: $365 million

How has Innospec revenue changed over the last 9 years?

Over the last 9 years, Innospec's total revenue changed from $1.01 billion in 2015 to $1.85 billion in 2024, a change of 82.3%.

How much debt does Innospec have?

Innospec's total liabilities were at $518.60 million at the end of 2024, a 7.0% decrease from 2023, and a 22.5% increase since 2015.

How much cash does Innospec have?

In the past 9 years, Innospec's cash and equivalents has ranged from $0.00 in 2017 to $289.20 million in 2024, and is currently $289.20 million as of their latest financial filing in 2024.

How has Innospec's book value per share changed over the last 9 years?

Over the last 9 years, Innospec's book value per share changed from 25.12 in 2015 to 48.56 in 2024, a change of 93.3%.

Related Companies

This page (NASDAQ:IOSP) was last updated on 5/31/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Innospec (IOSP) Financials

Frequently Asked Questions About Innospec's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Innospec (IOSP) Financials

Annual Income Statements for Innospec

Quarterly Income Statements for Innospec

Annual Cash Flow Statements for Innospec

Quarterly Cash Flow Statements for Innospec

Annual Balance Sheets for Innospec

Quarterly Balance Sheets for Innospec

Annual Metrics And Ratios for Innospec

Quarterly Metrics And Ratios for Innospec

Frequently Asked Questions About Innospec's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools